RedShift BioAnalytics attracts $11 mln
Burlington, Massachusetts-based RedShift BioAnalytics Inc, a maker of bioanalytical tools for the life science market, has raised $11 million in Series C financing. Waters Corporation and Technology Venture Partners led the round.
14 March 2017•1 min read
